2023
Exports
$196MWorld Rnk 33 / 208
Flag Rnk 106 / 1200
2023
PRODUCT COMPLEXITY IN Vaccines, blood, antisera, toxins and cultures
1.25Rnk 89 / 1025
2023
Imports
$2.82BWorld Rnk 19 / 222
Flag Rnk 8 / 1186
2023
ECONOMIC COMPLEXITY of Russia
0.3Rnk 50 / 132

About

Exports In 2023, Russia exported $196M in Vaccines, blood, antisera, toxins and cultures, making it the 33rd largest exporter of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 106th most exported product in Russia. The main destination of Vaccines, blood, antisera, toxins and cultures exports from Russia are: Kazakhstan ($49.4M), Nicaragua ($29.7M), Uzbekistan ($27.2M), Uganda ($15.8M), and Turkey ($11.8M).

The fastest growing export markets for Vaccines, blood, antisera, toxins and cultures of Russia between 2022 and 2023 were Nicaragua ($24.1M), Turkey ($11.2M), and Austria ($6.45M).

Imports In 2023, Russia imported $2.82B in Vaccines, blood, antisera, toxins and cultures, becoming the 19th largest importer of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 8th most imported product in Russia. Russia imports Vaccines, blood, antisera, toxins and cultures primarily from: Switzerland ($849M), Germany ($426M), Belgium ($360M), Slovenia ($264M), and Sweden ($236M).

The fastest growing import markets in Vaccines, blood, antisera, toxins and cultures for Russia between 2022 and 2023 were Sweden ($163M), Netherlands ($28.7M), and Slovenia ($9.34M).

Latest Trends

Dec 2024

Subnational Monthly Trade

View
Flow
Y-AXIS SCALE

For a full breakdown of trade patterns, visit the trend explorer or the product in country profile.

The following visualization shows the latest trends on Vaccines, blood, antisera, toxins and cultures. Countries are shown based on data availability.

* Using January 2020 exchange rates when trade data is reported in local currency.

Explore Latest Trends

Subscribe today to OEC pro and access the latest data

Sign Up

Historical Data

Trade Balance

Color
EXPORTS (2023)$196M
IMPORTS (2023)$2.82B
NET TRADE (2023)-$2.62B

In 2023, Russia exported $196M in Vaccines, blood, antisera, toxins and cultures. The main destinations of Russia exports on Vaccines, blood, antisera, toxins and cultures were Kazakhstan ($49.4M), Nicaragua ($29.7M), Uzbekistan ($27.2M), Uganda ($15.8M), and Turkey ($11.8M).

In 2023, Russia imported $2.82B in Vaccines, blood, antisera, toxins and cultures, mainly from Switzerland ($849M), Germany ($426M), Belgium ($360M), Slovenia ($264M), and Sweden ($236M).

Explore Visualizations

Export Destinations (2023)

Import Origins (2023)

Market Growth

Flow
THE FASTEST GROWING Vaccines, blood, antisera, toxins and cultures EXPORT MARKETS FOR Russia WERE (2022 - 2023):
Nicaragua$24.1M (436%)
Turkey$11.2M (2.11k%)
Austria$6.45M (272k%)
THE FASTEST DECLINING MARKETS FOR THE EXPORT OF Vaccines, blood, antisera, toxins and cultures BY Russia WERE (2022 - 2023):
Guatemala-$32.4M (-100%)
Vietnam-$24.8M (-100%)
Morocco-$7.56M (-43.9%)

Change in Exports by Market (2022 - 2023)

Market Concentration

View
Flow
Type
In 2023, Russia's main exporting competitors in Vaccines, blood, antisera, toxins and cultures were:
In 2023, Russia's main importing competitors in Vaccines, blood, antisera, toxins and cultures were:

Explore Visualizations

Trade Value of Vaccines, blood, antisera, toxins and cultures by Exporters

Potential Exports

Potential Exports

Flow
View
TOP EXPORT POTENTIALUnited States+ $7.05M
TOP IMPORT POTENTIALGermany+ $242M

Vaccines, blood, antisera, toxins and cultures’s highest export potential is United States. With an export gap of $7.05M.   Vaccines, blood, antisera, toxins and cultures’s highest import potential is Germany with an import gap of $242M.

See methodology.

Subscribe today to OEC pro and access the latest data

Sign Up

Have questions, comments, or concerns?
Send us an e-mail: support@oec.world
Follow @OECtoday on
Created, Designed, and Developed by:
In collaboration with